Fred Vogt
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Fred Vogt
Fred Vogt is recorded as CEO at Iovance Biotherapeutics, Inc. (IOVA). Fred Vogt has spoken on 11 earnings calls across 1 company, most recently for Iovance Biotherapeutics, Inc. on November 6, 2025.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Iovance Biotherapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Frederick G. Vogt, Ph.D. CEO
- Frederick Vogt CEO, General Counsel
- Corleen Roche CFO
- Jean-Marc Bellemin CFO
- Igor Bilinsky COO
- Igor Bilinsky, Ph.D. COO
- Matthew W. Rosinack Chief Accounting Officer
- Michael C. Swartzburg Chief Accounting Officer
- Athena Countouriotis Board Member
- Iain Dukes Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.